BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3865750)

  • 21. HLA antigens in Asian Indian patients with Graves' disease.
    Tandon N; Mehra NK; Taneja V; Vaidya MC; Kochupillai N
    Clin Endocrinol (Oxf); 1990 Jul; 33(1):21-6. PubMed ID: 2401095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA association in Singapore children with Grave's disease.
    Tan Siok-Hoon ; Chan Soh-Ha ; Lee Bee-Wah ; Wee Guan-Bock ; Wong Hock-Boon
    Metabolism; 1988 Jun; 37(6):518-9. PubMed ID: 3374318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The distribution of HLA-A, B, DR antigens in Chinese population.
    Huang CC
    Taiwan Yi Xue Hui Za Zhi; 1983 Sep; 82(9):967-71. PubMed ID: 6581268
    [No Abstract]   [Full Text] [Related]  

  • 24. Patients with Graves' disease who developed insulin autoimmune syndrome (Hirata disease) possess HLA-Bw62/Cw4/DR4 carrying DRB1*0406.
    Uchigata Y; Kuwata S; Tsushima T; Tokunaga K; Miyamoto M; Tsuchikawa K; Hirata Y; Juji T; Omori Y
    J Clin Endocrinol Metab; 1993 Jul; 77(1):249-54. PubMed ID: 8325948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-BW35 and B5 in Japanese patients with Graves' disease.
    Kawa A; Nakamura S; Nakazawa M; Sakaguchi S; Kawabata T; Maeda Y; Kanehisa T
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):754-7. PubMed ID: 579034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA class I and II antigens in South African blacks with Graves' disease.
    Omar MA; Hammond MG; Desai RK; Motala AA; Aboo N; Seedat MA
    Clin Immunol Immunopathol; 1990 Jan; 54(1):98-102. PubMed ID: 2293909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA typing in hashitoxic periodic paralysis.
    Leung AK
    West J Med; 1985 Aug; 143(2):252. PubMed ID: 3839955
    [No Abstract]   [Full Text] [Related]  

  • 28. [Thyrotoxic periodic paralysis and Graves' disease. Description of an HLA-CW7-positive case].
    Pandolfi C; Pellegrini L; Vitelli E; Sbalzarini G
    Minerva Endocrinol; 1991; 16(3):153-5. PubMed ID: 1666906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The HLA-DQ associations with Graves' disease in Chinese children.
    Wong GW; Cheng SH; Dorman JS
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):493-5. PubMed ID: 10468909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-polarized cell surface expression of HLA-A,B,C and HLA-DR antigens in Graves' thyroid follicle cells.
    Mölne J; Nilsson M; Jansson S; Hansson G; Ericson LE
    Autoimmunity; 1991; 10(3):189-99. PubMed ID: 1756224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human lymphocyte antigens (HLA) and Graves' disease in Turkey.
    Orhan Y; Azezli A; Carin M; Aral F; Sencer E; Molvalilar S
    J Clin Immunol; 1993 Sep; 13(5):339-43. PubMed ID: 7902362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic differences shown by HLA typing among Japanese patients with euthyroid Graves' ophthalmopathy, Graves' disease and Hashimoto's thyroiditis: genetic characteristics of euthyroid Graves' ophthalmopathy.
    Inoue D; Sato K; Maeda M; Inoko H; Tsuji K; Mori T; Imura H
    Clin Endocrinol (Oxf); 1991 Jan; 34(1):57-62. PubMed ID: 2004473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Human leukocyte antigen (HLA) complex and anti-thyroidal antibodies in Graves' disease].
    Lacka K; Kordel M; Gembicki M
    Pol Tyg Lek; 1989 Feb 13-20; 44(7-8):179-81. PubMed ID: 2682567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter.
    Schleusener H; Schernthaner G; Mayr WR; Kotulla P; Bogner U; Finke R; Meinhold H; Koppenhagen K; Wenzel KW
    J Clin Endocrinol Metab; 1983 Apr; 56(4):781-5. PubMed ID: 6131902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-A, -B, -C and -DR antigens in patients with Graves' disease and their correlation with signs and clinical course.
    Dahlberg PA; Holmlund G; Karlsson FA; Säfwenberg J
    Acta Endocrinol (Copenh); 1981 May; 97(1):42-7. PubMed ID: 6164233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneity by cluster analysis techniques of Graves' patients typed for HLA DR and IgG heavy chain markers.
    Frecker MF; Preus M; Kozma L; Krasrits E; Stenszky V; Balazś C; Farid NR
    Mol Biol Med; 1986 Feb; 3(1):63-71. PubMed ID: 3083192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of HLA with Graves' disease in Chinese.
    Tong ZH; Zhu G; Yan LX; Zhu J; Feng YG; Xu G
    Chin Med J (Engl); 1987 Apr; 100(4):296-8. PubMed ID: 3115694
    [No Abstract]   [Full Text] [Related]  

  • 38. Schizophrenic disorders and HLA-DR antigens.
    Miyanaga K; Machiyama Y; Juji T
    Biol Psychiatry; 1984 Feb; 19(2):121-9. PubMed ID: 6585231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of HLA antigen BW35 with severe Graves' ophthalmopathy.
    Sergott RC; Felberg NT; Savino PJ; Blizzard JJ; Schatz NJ; Sanford CA
    Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):124-7. PubMed ID: 6600737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of HLA-DR tissue types with Graves' disease in Taiwan.
    Tsai KS; Hsieh RP; Chang CC; Chen FW; Lee SC
    Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):336-41. PubMed ID: 2794934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.